-
5-(4-fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-N-(2-hydroxyphenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrole-3-carboxamide
-
ChemBase ID:
170256
-
Molecular Formular:
C33H33FN2O5
-
Molecular Mass:
556.6239232
-
Monoisotopic Mass:
556.23735039
-
SMILES and InChIs
SMILES:
c1(c(c(n(c1C(C)C)CC[C@@H]1C[C@H](CC(=O)O1)O)c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1O
Canonical SMILES:
O[C@@H]1C[C@@H](CCn2c(C(C)C)c(c(c2c2ccc(cc2)F)c2ccccc2)C(=O)Nc2ccccc2O)OC(=O)C1
InChI:
InChI=1S/C33H33FN2O5/c1-20(2)31-30(33(40)35-26-10-6-7-11-27(26)38)29(21-8-4-3-5-9-21)32(22-12-14-23(34)15-13-22)36(31)17-16-25-18-24(37)19-28(39)41-25/h3-15,20,24-25,37-38H,16-19H2,1-2H3,(H,35,40)/t24-,25-/m1/s1
InChIKey:
MNECBMZJZFGTIK-JWQCQUIFSA-N
-
Cite this record
CBID:170256 http://www.chembase.cn/molecule-170256.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
5-(4-fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-N-(2-hydroxyphenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrole-3-carboxamide
|
|
|
IUPAC Traditional name
|
5-(4-fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-N-(2-hydroxyphenyl)-2-isopropyl-4-phenylpyrrole-3-carboxamide
|
|
|
Synonyms
|
5-(4-Fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide
|
2-Hydroxy Atorvastatin Lactone
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
8.755879
|
H Acceptors
|
4
|
H Donor
|
3
|
LogD (pH = 5.5)
|
5.7478137
|
LogD (pH = 7.4)
|
5.729464
|
Log P
|
5.7480526
|
Molar Refractivity
|
156.6871 cm3
|
Polarizability
|
61.78042 Å3
|
Polar Surface Area
|
100.79 Å2
|
Rotatable Bonds
|
8
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
H828955
|
A metabolite of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. |
PATENTS
PATENTS
PubChem Patent
Google Patent